Latest News
Commentary
DTC genetic health risk tests: Beware
The Food and Drug Administration recently authorized 23andMe to provide consumers with results of germline DNA sequence variants associated with...
Feature
As some holdout states revisit Medicaid expansion, new data show it pays off
Although the GOP-controlled Congress is pledging its continued interest – despite stalls and snags – in dismantling Obamacare, some “red state”...
Feature
Medicaid reform: Work-based waivers may not fly
High mandatory premiums, cost sharing, lifetime limits, drug testing move Medicaid from a health care program to a work program, advocates argue...
Feature
CMS market stabilization efforts useless without subsidies
President Trump has threatened to withhold insurer subsidies in an effort to bring Congressional Democrats to the health care negotiation table....
From the Journals
Both diabetes types increase markedly among youths
Both types 1 and 2 diabetes increased markedly among youths between 2002 and 2012, especially among those in minority racial and ethnic groups.
Conference Coverage
Bundled maternal HIV, well-baby visits boost ART adherence
SEATTLE – When new moms can get their well-baby visits and HIV care together, they have better antiretroviral adherence and breastfeed longer.
From the Journals
Young patients with first-episode psychosis face far higher mortality risk
Insured young patients with first-episode psychosis have a mortality risk that is 24 times higher than that of their peers in the general...
News
Number of U.S. Zika-infected pregnancies tops 5,100
Almost 200 cases of Zika virus infection among pregnant women were reported during the 2 weeks ending March 28.
News
FDA approves first home genetic health risk test
Consumers do seem to want to know.
From the Journals
Inpatient cost of atopic dermatitis called ‘substantial’
Financial burden and hospitalization prevalence of atopic dermatitis is rising in the U.S.
News
Safety of N9-GP for hemophilia B needs further study, FDA committee agrees
The investigational factor IX product nonacog beta pegol for the treatment of hemophilia B has a possible safety issue that had the Food and Drug...